Explore / Clinical trial
Clinical trial

Repeated Neurocognitive Measurements in Depressed Patients

Jay FournierWithdrawnPhase 1Started May 1, 20250 enrolledUnited StatesNCT05991232

Abstract

In this project, we will A) track the functioning of a collection of potential neurobiological targets for depression over time, B) examine how fluctuations in the functioning of those targets relates to real-world functioning, and C) in a subset of the sample, determine how the functioning in those targets is altered by a single dose of ketamine.

Topics & conditions

Detected automatically by Psychedelic Commons from the title and abstract, not labels from the source. They may be incomplete.

KetamineDepression

Keywords

Depressive DisorderMood DisordersMental DisordersAnalgesicsSensory System AgentsPeripheral Nervous System AgentsPhysiological Effects of DrugsAnesthetics, DissociativeAnesthetics, IntravenousAnesthetics, GeneralAnestheticsCentral Nervous System DepressantsExcitatory Amino Acid AntagonistsExcitatory Amino Acid AgentsNeurotransmitter Agents

Psychedelic Commons aggregates metadata from open sources and links back to the original. Rights remain with the authors and publishers. Something wrong with this record? Report a problem.